Table 1 Baseline characteristics of exit interview participants by HIV status
From: Tuberculosis diagnosis cascade in Blantyre, Malawi: a prospective cohort study
HIV+ (N = 292) | HIV- (N = 1809) | Don’t know/never tested (N = 296) | P value | |
|---|---|---|---|---|
Sex (Female) | 213 (72.9%) | 1134 (62.7%) | 150 (50.7%) | < 0.001 |
Age Median (Range) | 36 (18–70) | 27 (18–87) | 27 (18–89) | < 0.001 |
Age 18–29 | 89 (30.5%) | 1031 (57.0%) | 159 (53.7%) | < 0.001 |
30–39 | 98 (33.6%) | 391 (21.6%) | 46 (15.5%) | |
40–49 | 68 (23.3%) | 190 (10.5%) | 25 (8.4%) | |
50–59 | 22 (7.5%) | 95 (5.3%) | 27 (9.1%) | |
60–89 | 15 (5.1%) | 102 (5.6%) | 39 (13.2%) | |
Cough | 121 (41.4%) | 618 (34.2%) | 110 (37.2%) | 0.044 |
Cough days (if cough) Median (Range) | 7 (1–3650) | 4 (1–2190) | 4 (2–1095) | 0.001 |
Chronic cough¶ | 44 (15.1%) | 149 (8.2%) | 28 (9.5%) | 0.001 |
Weight loss | 65 (22.3%) | 223 (12.3%) | 28 (9.5%) | < 0.001 |
Fever | 92 (31.5%) | 550 (30.4%) | 92 (31.1%) | 0.915 |
Night sweats | 56 (19.2%) | 342 (18.9%) | 63 (21.3%) | 0.629 |
Any symptoms† | 181 (62.0%) | 1007 (55.7%) | 182 (61.5%) | 0.035 |
Previous TB | 66 (22.6%) | 66 (3.6%) | 9 (3.0%) | < 0.001 |
On TB treatment* | 18 (14.9%) | 20 (3.2%) | 2 (1.8%) | < 0.001 |
TB treatment last 6 months* | 2 (1.7%) | 7 (1.1%) | 0 (0.0%) | 0.446 |
On IPT* | 26 (21.5%) | 7 (1.1%) | 2 (1.8%) | < 0.001 |
ART | 276 (94.5%) | 0 (0%) | 0 (0%) | < 0.001 |
Self-reported general health | ||||
Very Good | 5 (1.7%) | 58 (3.2%) | 13 (4.4%) | 0.062 |
Good | 159 (54.5%) | 1091 (60.3%) | 159 (53.7%) | |
Fair | 122 (41.8%) | 622 (34.4%) | 119 (40.2%) | |
Poor/Very poor | 6 (2.1%) | 38 (2.1%) | 5 (1.7%) | |